Bruno de Paula

Rethinking cancer clinical trials for COVID-19 and beyond

Gary J. Doherty, Mehmet Göksu, Bruno de Paula · Nature Cancer · 2020 · 50 citations · Full text

Medicine, Clinical Sciences, Oncology +12

Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic

Bruno de Paula, Indiara Iris de Oliveira Araújo, Lívia Liberata Barbosa Bandeira et al. · The Lancet Oncology · 2020 · 33 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Abstract PS11-05: Updated data from SERENA-1: A Phase 1 dose escalation and expansion study of the next generation oral SERD AZD9833 as a monotherapy and in combination with palbociclib, in women with ER-positive, HER2-negative advanced breast cancer

Richard D. Baird, Mafalda Oliveira, Eva María Ciruelos Gil et al. · Cancer Research · 2021 · 32 citations

Medicine, Oncology, Pharmacology +15

Real-world assessment of the effect of impact of tumor size on pathological complete response rates in triple negative breast cancer after neoadjuvant chemotherapy

Bruno de Paula, Sanjeev Kumar, Fabiola Marques Morosini et al. · Chinese Clinical Oncology · 2020 · 18 citations · Full text

Medicine, Biostatistics, Oncology +17

Abstract P3-07-28: SERENA-1: Updated analyses from a Phase 1 study of the next generation oral selective estrogen receptor degrader camizestrant (AZD9833) combined with abemaciclib, in women with ER-positive, HER2-negative advanced breast cancer

Nicholas C. Turner, Christos Vaklavas, Emiliano Calvo et al. · Cancer Research · 2023 · 14 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17